Evaluation of the association of single nucleotide polymorphisms in the sodium glucose cotransporter 2 gene with glucose homeostasis and type 2 diabetes

被引：0
|
作者：
Muendlein, Axel [1 ]
Ebner, Janine [1 ]
Leiherer, Andreas [1 ,3 ]
Saely, Christoph [1 ,2 ,3 ]
Geiger, Kathrin [1 ]
Brandtner, Eva-Maria [1 ]
Zanolin, Daniela [1 ]
Vonbank, Alexander [1 ,2 ]
Ebner, Karl-Martin [1 ,2 ]
Schuler, Alexandra [1 ,2 ]
Schwerzler, Peter [1 ,2 ]
Mader, Arthur [1 ,2 ]
Fraunberger, Peter [5 ]
Drexel, Heinz [1 ,3 ,4 ]
机构：
[1] VIVIT Inst, Feldkirch, Austria
[2] Acad Teaching Hosp, Feldkirch, Austria
[3] Private Univ Principal Liechtenstein, Triesen, Liechtenstein
[4] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[5] Med Cent Lab, Feldkirch, Austria
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2017年 / 129卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P08
引用
收藏
页码：S122 / S122
页数：1
相关论文
共 50 条
  • [41] Dapagliflozin: A new sodium-glucose cotransporter 2 inhibitor for treatment of type 2 diabetes
    Vivian, Eva M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (05) : 361 - 372
  • [42] Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes
    Abdul-Ghani, Muhammad A.
    Norton, Luke
    DeFronzo, Ralph A.
    ENDOCRINE REVIEWS, 2011, 32 (04) : 515 - 531
  • [43] Sodium-Glucose Cotransporter 2 Inhibition in Type 1 Diabetes: Simultaneous Glucose Lowering and Renal Protection?
    Cherney, David Z. I.
    Perkins, Bruce A.
    CANADIAN JOURNAL OF DIABETES, 2014, 38 (05) : 356 - 363
  • [44] Role of sodium glucose cotransporter-2 inhibitors in type I diabetes mellitus
    Ahmadieh, Hala
    Ghazal, Nisrine
    Azar, Sami T.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2017, 10 : 161 - 167
  • [45] Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus
    Abdul-Ghani, Muhammad A.
    Norton, Luke
    DeFronzo, Ralph A.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2015, 309 (11) : F889 - F900
  • [46] Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes
    Chang, Hsien-Yen
    Singh, Sonal
    Mansour, Omar
    Baksh, Sheriza
    Alexander, G. Caleb
    JAMA INTERNAL MEDICINE, 2018, 178 (09) : 1190 - 1198
  • [47] Association of Sodium-Glucose Cotransporter-2 Inhibitors With Incident Atrial Fibrillation in Older Adults With Type 2 Diabetes
    Zhuo, Min
    D'Andrea, Elvira
    Paik, Julie M.
    Wexler, Deborah J.
    Everett, Brendan M.
    Glynn, Robert J.
    Kim, Seoyoung C.
    Patorno, Elisabetta
    JAMA NETWORK OPEN, 2022, 5 (10) : E2235995
  • [48] Use of Sodium-Glucose Cotransporter Type 2 Inhibitors in Older Adults with Type 2 Diabetes Mellitus
    Mikhail, Nasser
    SOUTHERN MEDICAL JOURNAL, 2015, 108 (02) : 91 - 96
  • [49] Cardiovascular and Renal Benefit of Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes
    Lam, Steven Ho Man
    Alam, Uazman
    Lip, Gregory Yoke Hong
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 223 : 183 - 185
  • [50] Dapagliflozin: A Novel Sodium-Glucose Cotransporter Type 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
    Shah, Niren K.
    Deeb, Wasim E.
    Choksi, Rushab
    Epstein, Benjamin J.
    PHARMACOTHERAPY, 2012, 32 (01): : 80 - 94
12345